Stanford team preps first human CRISPR study for sickle cell disease cure; Shkreli fingers his former attorneys
Stanford scientists say they have been able to use CRISPR gene editing tech to correct a faulty gene that triggers sickle cell disease. And …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
